467 related articles for article (PubMed ID: 16608626)
21. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
[TBL] [Abstract][Full Text] [Related]
22. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
24. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
25. A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.
Elston MS; Stewart IJ; Clifton-Bligh R; Conaglen JV
Bone; 2007 Jan; 40(1):236-41. PubMed ID: 16982223
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic osteomalacia from pterygopalatine fossa mass.
Savage CR; Zimmer LA
J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
[TBL] [Abstract][Full Text] [Related]
27. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia.
Kimizuka T; Ozaki Y; Sumi Y
Ann Nucl Med; 2004 Feb; 18(1):63-7. PubMed ID: 15072186
[TBL] [Abstract][Full Text] [Related]
29. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
30. Glomangiopericytoma causing oncogenic osteomalacia. A case report with immunohistochemical analysis.
Sakamoto A; Oda Y; Nagayoshi Y; Iwakiri K; Tamiya S; Iwamoto Y; Tsuneyoshi M
Arch Orthop Trauma Surg; 2001; 121(1-2):104-8. PubMed ID: 11195105
[TBL] [Abstract][Full Text] [Related]
31. Osteomalacia as a very late manifestation of primary hyperparathyroidism.
Kaplan FS; Soffer SR; Fallon MD; Haddad JG; Dalinka M; Raffensperger EC
Clin Orthop Relat Res; 1988 Mar; (228):26-32. PubMed ID: 3342577
[TBL] [Abstract][Full Text] [Related]
32. [The clinical characteristics of 26 cases of hypophosphatemia osteomalacia misdiagnosed as spondyloarthritis].
Jin J; Sun F; Wang G; Yang J; Luo G; Ma H; Zhao Z; Feng L; Wang Y; Zhao W; Zhang J; Zhu J; Huang F
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):847-51. PubMed ID: 25586353
[TBL] [Abstract][Full Text] [Related]
33. Tumor-induced osteomalacia: clinical and basic studies.
Shane E; Parisien M; Henderson JE; Dempster DW; Feldman F; Hardy MA; Tohme JF; Karaplis AC; Clemens TL
J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
[TBL] [Abstract][Full Text] [Related]
34. A rare combination of tumor-induced osteomalacia caused by sinonasal glomangiopericytoma and coexisting parathyroid adenoma: case report and literature review.
Brociek-Piłczyńska A; Brodowska-Kania D; Szczygielski K; Lorent M; Zieliński G; Kowalewski P; Jurkiewicz D
BMC Endocr Disord; 2022 Jan; 22(1):31. PubMed ID: 35090436
[TBL] [Abstract][Full Text] [Related]
35. Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren's syndrome: a case report and review of the literature.
Geng Y; Zhao Y; Zhang Z
Clin Rheumatol; 2018 Jan; 37(1):257-263. PubMed ID: 28725949
[TBL] [Abstract][Full Text] [Related]
36. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
Alonso G; Varsavsky M
Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
[TBL] [Abstract][Full Text] [Related]
37. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
Sato K; Nohtomi K; Demura H; Takeuchi A; Kobayashi T; Kazama J; Ozawa H
Bone; 1997 Jul; 21(1):57-64. PubMed ID: 9213008
[TBL] [Abstract][Full Text] [Related]
38. Bone densitometry in a patient with hypophosphatemic osteomalacia.
Negri AL; Bogado CE; Zanchetta JR
J Bone Miner Metab; 2004; 22(5):514-7. PubMed ID: 15316875
[TBL] [Abstract][Full Text] [Related]
39. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
Weiss M; Schechter P; Bab I; Mekhmandarov S; Bank H; Eisenstein Z
Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.
Fuentealba C; Pinto D; Ballesteros F; Pacheco D; Boettiger O; Soto N; Fernandez W; Gabler F; Gonzales G; Reginato AJ
J Clin Rheumatol; 2003 Dec; 9(6):373-9. PubMed ID: 17043447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
